| Dianne J Abel, PA-C | |
|
Nmrtu Atsugi, Naf Atsugi, Bldg 21, Fpo, AP 96306 | |
| (315) 264-3959 | |
| Not Available |
| Full Name | Dianne J Abel |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | Nmrtu Atsugi, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407364193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dianne J Abel, PA-C Psc 477 Box 2, Fpo, AP 96306-0001 Ph: () - | Dianne J Abel, PA-C Nmrtu Atsugi, Naf Atsugi, Bldg 21, Fpo, AP 96306 Ph: (315) 264-3959 |
News Archive
Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.
This year marks both the 10th anniversary of the Affordable Care Act (ACA), and a pivotal moment for its future because of the national election and a pending Supreme Court case.
In patients with an acute heart attack, remote ischemic conditioning - intermittent inflation of a blood pressure cuff to cut off blood flow to the arm during transportation to hospital for acute balloon dilatation - reduces subsequent cardiac symptoms and mortality after acute heart attack.
Censis® Technologies, Inc., developer of Censitrac™ surgical instrument tracking systems, has introduced ScopeTrac, an endoscope tracking and reprocessing data management solution designed to help prevent inappropriate endoscope reprocessing.
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
› Verified 1 days ago
Byanca Bevett, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Psc 561 Box 1877, Fpo, AP 96310 Phone: 315-243-8649 | |
Jenny Anne Oliver, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: United States Naval Hospital Okinawa Bldg 960, Fpo, AP 96362 Phone: 315-646-7312 | |
Dale C Limbrock, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3d Medical Battalion, Unit 38445, Fpo, AP 96373 Phone: 011-816-1197 | |
Mr. Daniel Leroy Anderson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Us Naval Hospital Okinawa, Fpo, AP 96350 Phone: 315-643-7555 | |
Mr. Clifton Da Carlos Butler, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Psc 466 Box 3, Fpo, AP 96595 Phone: 246-370-4200 | |
Jessica Mae Martin, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: Psc 477 Box 2, Fpo, AP 96306 Phone: 011-818-035346794 | |
James Alan Ruley, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: Psc 482, Fpo, AP 96362 Phone: 010-314-27308 |